Table 2.
Modification of plant N-glycan by glycoengineering to make protein compatible for functioning in humans
S/N | Amino Acid | Glycomoeity | Enzymes involved | Resultants Glycostructure | Application | References |
---|---|---|---|---|---|---|
A | -ASN- |
![]() |
Xylosyltranferases&fucosyltransferases (Genetic knock-out) |
![]() |
Chinese hamster ovary (CHO)-derived immunoglobulins (IgGs) was produced in plants which do not show any difference in Enzyme-link immunosorbent specificity assay | [82, 83] |
B | -ASN- |
![]() |
Galactosyltransferases |
![]() |
Production of recombinant immunoglobulin which does not serve as a substrate for plant specific xylose and fucose | [74] |
C | -ASN- |
![]() |
β1,4-galactosyltranferases |
![]() |
Production of antibody similar to the one produced by hybridoma technology | [76, 84] |
D | -ASN- |
![]() |
β1,4-galactosyltransferase with RNAi of fucosyl- and xylosyltranferases |
![]() |
Production of human-compatible antibody | [84] |
E | -ASN- |
![]() |
Xylosyl and fucosyltransferases, β1,4-galactosyltransferase, & α2,6-sialyltransferase |
![]() |
Introduced sialic acid to the plant-derived proteins | [80] |
F | -ASN- |
![]() |
α1,3-fucosyltransferase and β1,4-galactosyltransferase |
![]() |
protected galactosylated N-glycans from endogenous plant β-galactosidase activity | [85] |